In vitro differentiation of human amniotic epithelial cells into insulin-producing 3D spheroids by Okere, Bernard et al.
International Journal of 
Immunopathology and Pharmacology
2015, Vol. 28(3) 390 –402
© The Author(s) 2015
Reprints and permissions: 
sagepub.co.uk/journalsPermissions.nav
DOI: 10.1177/0394632015588439
iji.sagepub.com
In vitro differentiation of human  
amniotic epithelial cells into insulin-
producing 3D spheroids
Bernard Okere,1* Francesco Alviano,2* Roberta Costa,2  
Daniela Quaglino,3 Francesca Ricci,4 Massimo Dominici,5  
Paolo Paolucci,1 Laura Bonsi2 and Lorenzo Iughetti1 
Abstract
Regenerative medicine and stem cell therapy may represent the solution for the treatment of non-curable human 
diseases such as type 1 diabetes. In this context of growing demand for functional and safe stem cells, human amniotic 
epithelial cells (hAECs) from term placenta have attracted increasing interest for their wide availability, stem cell 
properties, and differentiation plasticity, which make them a promising tool for stem cell-based therapeutic applications. 
We initially assayed the stemness characteristics of hAECs in serum-free conditions. Subsequently we developed a 
culture procedure on extracellular matrix for the formation of three-dimensional (3D) spheroids. Finally, we tested the 
immunomodulation and differentiation potential of hAEC spheroids: the presence of pancreatic endocrine hormones 
was revealed with transmission electron microscopy and immunofluorescence analyses; the release of C-peptide in 
hyperglycemic conditions was assayed with ELISA.
The serum-free culture conditions we applied proved to maintain the basic stemness characteristics of hAECs. We 
also demonstrated that 3D spheroids formed by hAECs in extracellular matrix can be induced to differentiate into 
insulin-producing cells. Finally, we proved that control and induced cells equally inhibit the proliferation of activated 
mononuclear cells.
The results of this study highlight the properties of amnion derived epithelial cells as promising and abundant source 
for cell-based therapies. In particular we are the first group to show the in vitro pancreatic induction of hAECs cultured 
on extracellular matrix in a 3D fashion. We accordingly propose the outcomes of this study as a novel contribution to 
the development of future cell replacement therapies involving placenta-derived cells.
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Introduction
Regenerative medicine and stem cell therapy rep-
resent promising tools for the treatment of non-
curable human diseases such as type 1 diabetes 
(T1D), which is characterized by the autoimmune 
destruction of pancreatic beta cells, resulting in the 
lack of insulin. The impairment of glucose homeo-
stasis functions causes hyperglycemia and serious 
long-term complications. The shortage of trans-
plantable pancreatic islets and the side effects of 
prolonged insulin injection to treat T1D,1 have 
stimulated research into expandable and renewable 
sources of insulin-producing cells (IPCs). Stem 
cells hold great promise for supplying an adequate 
amount of donor cells for replacement therapies. In 
this connection, human embryonic stem cells 
(hESCs) and induced pluripotent stem (iPS) cells 
represent a virtually unlimited source of transplant-
able cells. Many studies have reported the deriva-
tion of IPCs from hESCs2 and iPS cells,3 but their 
future clinical application is hampered by the han-
dling complexity, high cost of procedures, safety 
issues, and ethical concerns.4 Stem cells isolated 
from other tissues may surmount the issues related 
to the use of hESCs and iPS cells. Among them, 
placenta-derived stem cells are a promising source 
for cell transplantation and regenerative medicine. 
Human term placenta and fetal membranes are dis-
carded after birth, so they can be easily obtained in 
large amounts without ethical concerns or invasive 
isolation procedures. Human amniotic epithelial 
cells (hAECs) are derived from human amniotic 
membrane and originate from epiblast at days 8–9 
during embryological development, before gastru-
lation.5 hAECs express markers associated with 
hESCs and pluripotent stem cells,6 but unlike 
hESCs, hAECs are considered a safe alternative 
for cell therapies since they do not cause teratomas 
upon transplantation nor activation of the immune 
system.7 Moreover, hAECs have been successfully 
induced to differentiate towards mesodermic 
lineage,8 neural-ectodermic lineage,9 hepatic-
endodermic lineage,10 and pancreatic-endodermic 
lineage.11 For all these reasons hAECs are consid-
ered to retain most of the stem cell peculiarities of 
hESCs. In addition, the immune privilege of pla-
cental tissue grants hAECs the unique characteris-
tic of being associated with poor antigenicity and 
immunomodulatory properties: in particular they 
inhibit mixed lymphocyte reactions as well as 
mitogen stimulated T cell proliferation in vitro12,13 
and they do not induce immune reaction when 
transplanted in vivo.7
Previous studies successfully described the iso-
lation and differentiation of hAECs into IPCs using 
classic or stepwise differentiation protocols,11 in 
the presence of media enriched with components 
of animal origin. The use of animal sera as growth 
supplement in human cell cultures might compro-
mise the reproducibility and reliability of down-
stream assays and, therefore, could hamper the 
chance of clinical translation.14,15
Along with the requirements related to culture 
media composition, it is likewise worthy of consid-
eration the adoption of culture methods that mimic 
the in vivo environment, such as three-dimensional 
(3D) culture systems. Several studies showed that 
stem cells cultured on 3D matrices enhance their 
ability to form higher-order structures like embry-
oid bodies, spheroids, and glandular-like acini.16,17 
Moreover, 3D matrices enhance the stem cell 
potential and viability, while providing the suitable 
microenvironment for cell attachment, prolifera-
tion, and differentiation.18 These effects are a direct 
consequence of the synergic cell-to-cell and cell-
to-ECM interactions that cannot be provided in 
classical monolayer cultures.19,20 In particular, 
recent cell therapies studies for diabetes showed 
that 3D cultures could play a crucial role in the 
induction of hESCs into mature IPCs.21
In this perspective, in the present study we vali-
dated the stemness and immunomodulatory prop-
erties of hAECs in defined serum free conditions. 
We successfully developed a serum-free 3D cul-
ture procedure, based on extracellular matrix 
(ECM) hydrogel, for multicellular hAEC spheroid 
formation. Finally, for the first time in the field of 
placental stem cell research, we demonstrated that 
hAECs cultured in 3D serum-free conditions, func-
tionally produce newly synthesized insulin in 
response to glucose stimulation.
Materials and methods
Ethics
The study was approved by the Local Research 
Ethics Committee (Azienda Ospedaliero-
Universitaria di Modena, prot. n 1171; 12/04/2010) 
and written informed consent was obtained from 
each healthy donor before specimen collection.
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Isolation and expansion of human amniotic 
epithelial cells (hAECs) in basal growth media 
(BM)
Amnion membranes were retrieved from term preg-
nancies (37–40 weeks of gestation) delivered by 
Cesarean section. hAECs were isolated using a 
modified procedure of the protocol previously 
reported by Ilancheran et al.:22 the amnion layer was 
mechanically peeled off the chorion layer and imme-
diately washed in Hank’s Balanced Wash Solution 
without calcium and magnesium (HBSS, PAA 
Laboratories GmbH, Pasching, Austria) until blood 
clots were completely removed. The amnion was 
minced into small pieces (4 cm2 approximately) and 
incubated for 10 min at 37°C with 1X trypsin-EDTA 
(PAA Laboratories) to exclude debris. Membranes 
were then incubated for a second and third 40 min 
enzymatic digestion to release the amniotic epithe-
lial cells. Single cell suspension was washed with 
Phosphate Buffered Saline (PBS, PAA Laboratories) 
and tested for viability with trypan blue dye 
(Biochrom AG, Berlin, Germany). Only samples 
with >90% viability were used for further assays.
Cell pellets were resuspended in serum-free 
medium (SFM), which consisted of Quantum286 
(PAA Laboratories) serum-free medium for epithe-
lial cells with 1% Penicillin-Streptomycin solution 
(PAA Laboratories) and epidermal growth factor 
(EGF) (10 ng/mL; Sigma-Aldrich, St. Louis, MO, 
USA), or serum-rich medium (SRM) made of 
DMEM (Invitrogen, Carlsbad, CA, USA) supple-
mented with heat-inactivated 10% fetal bovine 
serum (FBS) (PAA Laboratories), 1% Penicillin-
Streptomycin solution (PAA Laboratories), and 
EGF (10 ng/mL; Sigma-Aldrich). The plating con-
centration in cell culture flasks was 80,000 cells/
cm2. Before further assays, the cells were allowed 
to attach to the substrate and grow in culture 
medium until 80–90% confluency.
Cell proliferation assay
In order to evaluate cell proliferation potential, 
hAECs were plated at 60,000 cells/cm2 in 24-well 
plates and cell growth was assessed using Alamar 
Blue assay. Alamar Blue 10% (Invitrogen) was 
added to basal medium (BM) for 4 h and then fluo-
rescence was measured using Victor Multilabel 
Counter (Perkin Elmer, Boston, MA, USA). The 
same procedure was repeated on days 3, 5, 8, 10, 
12, and 15. Data were plotted as Fluorescence 
Arbitrary Unit (AU fluorescence) analyzed at spe-
cific time points.
Flow cytometric characterization of hAECs
Flow cytometric analysis was performed on pri-
mary cultures of hAECs. Cells were detached with 
Trypsin-EDTA and incubated with antibodies 
(1 µg/mL for 30 min at 4°C). The antibodies used 
were: anti-CD105-FITC (Beckman Coulter, 
Miami, FL, USA), anti-panCytokeratin-PE (Santa 
Cruz Biotechnology, Santa Cruz, CA, USA), anti-
SSEA-4-APC (R&D Systems, Minneapolis, MN, 
USA), anti-OCT4 primary antibody (Santa Cruz 
Biotechnology), and secondary anti-mouse IgG-
FITC (Beckman Coulter). Cells were then washed 
and analyzed on a flow cytometer (Navios FC, 
Beckman Coulter); acquired data were elaborated 
with Kaluza FC Analysis software.
RNA isolation, reverse transcription and  
real-time PCR (qPCR)
Total RNA was extracted from hAECs grown in cul-
ture flasks using the PureLink RNA Mini Kit 
(Invitrogen) according to the manufacturer’s instruc-
tions. cDNA was synthesized from 1–2 µg of total 
RNA using RETROscript First Strand Synthesis Kit 
and oligo dT (Invitrogen). Oligonucleotide pairs 
were designed using qPCR SciTools software 
(Integrated DNA Technologies). Primer sequences 
and gene accession numbers for stemness gene 
markers (Ki67, OCT4a, NANOG, SOX2) are listed 
in Table 1. qPCR assays were performed in a 
StepOne System (Applied Biosystems, Foster City, 
CA, USA) with KAPA SYBR FAST Master Mix 
(KAPA BIOSYSTEMS, Woburn, MA, USA). Data 
were normalized against the internal control beta-
actin (ACTB).
Immunomodulatory properties of hAECs
In order to evaluate the immunomodulatory poten-
tial of hAECs on activated peripheral blood mono-
nuclear cells (PBMCs), hAECs were plated in 
6-well plates (60,000 cells/cm2) in SFM or SRM, 
and were allowed to stabilize in culture for 7 days. 
Then, PBMCs were isolated from healthy donors by 
density gradient centrifugation (Ficoll-Paque 1077, 
Sigma-Aldrich) and plated on hAEC monolayer at a 
Okere et al. 393
density of 2 × 106 cells/well in RPMI 1640 (Lonza, 
Walkersville, MD, USA). PBMCs were activated by 
addition of Phytohemagglutinin (PHA, 5 µg/mL, 
Sigma-Aldrich) and incubated for 72 h at 37°C, 5% 
CO2. Finally PBMCs were resuspended, recovered, 
and fixed with 70% ethanol at 4°C, stained with 
Propidium Iodide (Beckman Coulter) at room tem-
perature for 10 min. The negative control consisted 
of PBMCs without PHA stimulation, while positive 
control was PBMCs with PHA (5 µg/mL) in the 
absence of hAECs. Cell cycle phase distribution of 
PBMCs was analyzed by flow cytometer.
Three-dimensional (3D) culture
3D culture of hAECs was performed according to 
the overlay method previously described by 
Debnath et al.16 Briefly, isolated hAECs were first 
resuspended in SFM added with 2.5% reduced 
growth factor basement membrane extract (BME) 
from Engelbreth-Holm-Swarm (EHS) mouse sar-
coma (Trevigen, Gaithersburg, MD, USA). Then, 
resuspended cells were seeded (60,000 cells/cm2) 
on a thick layer of 100% reduced growth factor 
BME measuring approximately 1 mm in thickness. 
Multicellular spheroids formed after 5–6 days, par-
tially embedded in the gelled layer of basement 
membrane. Cell culture medium was changed 
every 3 days. hAEC spheroids were harvested and 
collected for further assays using Cultrex 3D cul-
ture cell harvesting kit (Trevigen Inc.).
In vitro pancreatic stepwise differentiation
Prior to differentiation, hAECs were allowed to 
grow for 5 days in SFM until the sufficient spheroid 
size. Pancreatic induction of 3D cultured cells was 
performed using a stepwise protocol divided into 
three stages: Stage 1: hAEC spheroids were pre-
differentiated for 4 days in SFM supplemented with 
100 ng/mL Activin A; Stage 2: SFM was supple-
mented with 100 ng/mL Activin A and Nicotinamide 
(NAM, 10mM) for 4 additional days; and Stage 3: 
terminal differentiation was performed switching 
the medium to SFM with NAM (10 mM) and 
Retinoic Acid (RA) (2 µM) for 10 days. Glucose 
concentration of SFM was ⩾15 mM. This hyper-
glycemic culture condition is suitable for epithelial 
cells growth and was maintained for pancreatic dif-
ferentiation assay to enhance the induction of 
hAECs into IPCs.23 Media supplements were all 
obtained from Sigma-Aldrich.
Immunofluorescence analysis and confocal 
microscopy
3D hAEC spheroids were fixed with 2% 
Paraformaldehyde (PFA, Sigma-Aldrich) for 20 
min at room temperature. After washing 2 × 10 min 
in PBS, spheroids were permeabilized in 0.5% 
Triton X-100 (Sigma-Aldrich) in PBS for 10 min 
and then rinsed again 2 × 10 min in PBS. Antigen 
blocking was performed for 1 h at room tempera-
ture in blocking solution: 5% normal goat serum 
(Vector Laboratories, Burlingame, CA, USA), 0.2% 
Triton x-100, 0.1% Bovine Serum Albumin (BSA) 
(Sigma-Aldrich). Primary and secondary antibod-
ies were diluted in freshly prepared blocking solu-
tion. Primary antibodies were incubated at 8°C 
overnight and secondary antibodies for 40–50 min 
at room temperature. The following primary anti-
bodies and dilutions were used: mouse anti-insulin 
1:100 (Abcam ab46707); rabbit anti-glucagon 
(Abcam ab8055); rabbit anti-C-peptide 1:100 (Cell 
Signalling #4593); rabbit anti-CK19 1:100 
(Thermo Scientific PA5-16726); mouse anti-
laminin 1:100 (Thermo Scientific MA1-21194). 
Secondary antibodies were: DyLight 594 goat anti-
mouse 1:200 (Jackson Immuno Research Labs.); 
Alexa Fluor 488 goat anti-rabbit 1:400 (Molecular 
Probes); CF 488 goat anti-mouse 1:400 (Biotium); 
DyLight 594 goat anti-rabbit 1:200 (Thermo 
Scientific). Nuclei counterstaining was performed 
with Fluoroshield+DAPI (Sigma-Aldrich). Imaging 
Table 1. PCR primers and gene accession number.
Gene Forward primer Reverse primer Accession no.
Ki67 TCC TAA TAC GCC TCT CAA AAG GAT TTC TGA ACC TGA CTC TTG NM_001145966
OCT4a AGA GAA AGC GAA CCA GTA TC TTA CAG AAC CAC ACT CGG NM_002701
NANOG AGA AAT ACC TCA GCC TCC AG CGT CAC ACC ATT GCT ATT CTT NM_024865
SOX2 CAG ACT TCA CAT GTC CCA G CTC CCA TTT CCC TCG TTT NM_003106
BETA-ACTIN CCT TCT ACA ATG AGC TGC G CCT GGA TAG CAA CGT ACA TG NM_001101
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was performed by confocal microscopy (Leica TCS 
SP2, Leica Microsystems, Mannheim, Germany) 
and images were processed using Leica Confocal 
Software.
Transmission electron microscopy (TEM)
Pancreatic induced hAECs cultured in 3D matrices 
and undifferentiated control cells were gently 
washed with Tyrode’s buffer, pH 7.3, and centri-
fuged at 10,000 x g for 5 min at 10°C. The result-
ing pellets were fixed overnight with 2.5% 
Glutaraldehyde (Electron Microscopy Sciences, 
Hatfield, PA, USA) in Tyrode’s buffer, postfixed 
for 2 h in 1% Osmium Tetroxide (Electron 
Microscopy Sciences), dehydrated, and embedded 
in Spurr resin (Electron Microscopy Sciences). 
Since cells were not homogeneously distributed 
within matrices, semi-thin sections were routinely 
stained with Toluidine Blue and observed with a 
Zeiss Axiophot light microscope (Carl Zeiss, Jena, 
Germany) to locate cells in each cut layer. Ultra-
thin sections were performed on areas selected for 
the presence of spheroids and observed with a Jeol 
2010 electron microscope (Jeol, Tokyo, Japan) at 
200 kV after staining with Uranyl Acetate and 
Lead Citrate (Electron Microscopy Sciences).
Glucose-stimulated release and expression of 
C-peptide
To confirm the synthesis of insulin, C-peptide 
release from differentiated and undifferentiated 
hAEC spheroids was measured in hypoglycemic 
and hyperglycemic conditions. First, cells were 
incubated in Krebs-Ringer solution with bicarbo-
nate and HEPES (KRBH; 129 mM NaCl, 4.8 mM 
KCl, 2.5 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM 
MgSO4, 5 mM NaHCO3, 10 mM HEPES, 0.1% 
(wt/vol) BSA) (Sigma-Aldrich) for 70 min as a 
preliminary washing step. Next, spheroids were 
incubated in KRBH with 2mM D-Glucose (Sigma-
Aldrich) for 1 h and then switched to hyperglyce-
mic stimulation condition consisting of KRBH 
with 20 mM D-Glucose and 30 mM KCl for 1 h. 
C-peptide levels in supernatant from basal (2 mM 
D-Glucose) and stimulation condition (20 mMD-
Glucose + 30 mM KCl) were measured using the 
Human Ultrasensitive C-peptide enzyme-linked 
immunosorbent assay (ELISA) kit (Mercodia, 
Uppsala, Sweden) and normalized to total amount 
of cellular DNA using CyQUANT Cell Proliferation 
Assays Kit (Invitrogen). The fold stimulation was 
calculated as the ratio of the C-peptide concentra-
tion in supernatant from hyperglycemic condition 
to the C-peptide concentration from hypoglycemic 
condition. Glucose-stimulated spheroids were 
immediately assayed for the presence of C-peptide 
with immunofluorescence analysis.
Immunomodulatory activity of hAEC spheroids
The immunomodulatory activity of hAECs was 
analyzed after stepwise pancreatic-endocrine dif-
ferentiation in 3D culture. PBMCs were isolated as 
previously described and plated on hAEC spheroids 
at the end of pancreatic differentiation protocol 
(hAECs/PBMCs ratio 1:2). PBMCs were activated 
by addition of Phytohemagglutinin (PHA) (5 µg/
mL; Sigma-Aldrich) and hAEC spheroids/PBMCs 
co-cultures were incubated for 72 h at 37°C, 5% 
CO2. The negative control consisted of PBMCs 
without PHA stimulation and the positive control 
was PBMCs with PHA (5 µg/mL) in the absence of 
hAEC spheroids. Finally PBMCs were resus-
pended, recovered, and plated in 96-wells plate for 
BrdU incorporation analysis. BrdU incorporation 
was evaluated using a colorimetric immunoassay, 
according to the manufacturer’s instructions (Cell 
Proliferation ELISA, BrdU – colorimetric kit, 
Roche, Basel, Switzerland).
Statistical analysis
The assays were repeated a minimum of three 
times independently and the results were expressed 
as the mean ± SD. Statistical analysis was per-
formed using two-tailed, paired T-test, or one-way 
ANOVA test. P <0.05 was considered to be statisti-
cally significant.
Results
hAEC epithelial morphology and proliferation 
rate
hAECs were isolated from term placenta and grew 
as adherent cells when seeded in classical serum-
rich medium (SRM) or in serum-free medium 
(SFM). In both culture conditions hAECs regularly 
proliferated and formed a confluent monolayer of 
cells with epithelial cobblestone-shaped morphol-
ogy (Figure 1a). In order to evaluate the culture 
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medium influence on hAEC growth kinetics and 
proliferation ability, we performed a cell growth 
assay for 15 days. The resulting growth curve 
showed a similar proliferation rate for hAECs in 
both SRM and SFM (Figure 1b).
Essential characterization of SFM-cultured 
hAECs
To evaluate the effects of culture media, we tested 
whether serum deprivation could influence hAEC 
stemness features and immunomodulatory proper-
ties. First, we examined the expression of a selected 
antigenic surface pattern (Figure 2a). Flow cyto-
metric analysis displayed a similar hAECs immu-
nophenotype for both cell culture media: protein 
expression levels of stemness markers, OCT4 and 
SSEA-4, were clearly positive (OCT4: 99.1 ± 0.2% 
in SRM and 99.3 ± 0.3% in SFM; SSEA-4: 97.3 ± 
0.4% in SRM and 98.9 ± 0.2% in SFM); character-
istic mesenchymal antigen CD105 was expressed 
(94.5 ± 0.5% in SRM and 93.7 ± 0.6% in SFM) as 
previously reported;8 distinctive epithelial marker 
PanCK was uniformly expressed in the hAECs 
population (99.9 ± 0.1% in SRM and 99.9 ± 0.1% 
in SFM). These data proved that SFM culture does 
not affect the immunophenotype of hAECs.
Moreover, qPCR was carried out to test for 
serum-induced changes in the expression of prolif-
erative gene Ki67 and stemness markers NANOG, 
SOX2, and OCT4a. Ki67 mRNA decrease in 
serum-free medium is not significant, while gene 
expression levels for stemness markers were 
clearly and significantly higher in serum-free con-
ditions than in serum-rich media, namely 70-fold 
for NANOG, 36-fold for SOX2, and 12-fold 
increase for OCT4a mRNA (Figure 2b).
Finally, to assess hAEC immunomodulatory 
ability in serum-free culture conditions, PHA-
stimulated PBMCs were co-cultured with hAECs 
in SRM and SFM, and their proliferation was 
assayed to test hAEC immunomodulatory proper-
ties. The distribution of PBMCs in the cell cycle 
phases was evaluated (Figure 2c). Non-activated 
PBMCs were all in G1-G0 phase (96.4 ± 0.3%), 
while activated PBMCs in the absence of hAECs 
significantly decreased in the G1-G0 phase (68.7 ± 
3.3%) and increased in the S (18.6 ± 0.5%) and 
G2-M (12.1 ± 2.0%) phases (P <0.05). After co-
culture with hAECs in SRM or SFM, we observed 
a significant increase of PBMCs in G1-G0 (83.0 ± 
4.1% in SRM and 82.7 ± 4.9 in SFM) and an equally 
sizable reduction of PBMCs in the S (11.5 ± 1.7 in 
SRM and 12.0 ± 0.6% in SFM) and G2-M (4.4 ± 
2.6% in SRM and 3.7 ± 2.6% in SFM) phases (P 
<0.05). We may assume from these observations 
that hAECs cultured in either SRM or SFM, simi-
larly reduce the proliferation of stimulated PBMCs.
Morphogenesis of hAEC spheroids grown in 3D 
culture
When cultured on a thick bed consisting of 100% 
gelled basement membrane extract (BME), hAECs 
adopted a spheroid, 3D morphology (Figure 3a). 
Figure 1. hAECs retain distinctive epithelial 
morphology and regular growth in serum free 
medium. (a) Phase-contrast morphology of hAECs grown 
as a monolayer in serum rich (SRM) (a, b) and serum free 
(SFM) culture media (c, d). Subconfluent hAECs (24 h following 
isolation) grew as isolated cells and clusters (a, c). Lamellipodia 
are visible (black arrows). At confluence, hAECs assumed 
a cobblestone morphology, typical of epithelial cells (b, d). 
Representative immunofluorescence (e) image shows hAEC 
immunoreactivity for CK19 marker; nuclei are counterstained 
with DAPI. Scale bars = 50 µm. (b) In vitro expansion of hAECs 
in SRM and SFM culture media. Cells were isolated and seeded 
at 60,000 cells/cm2, and cell proliferation was analyzed for 15 
days. Data are expressed as arbitrary units of fluorescence (AU 
Fluorescence). Means ± SD; n = 3.
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After 1 week of culture, we observed the forma-
tion of multicellular structures which increased in 
complexity, size, and cellular density over time, 
reaching a complete and definitive spheroid archi-
tecture (> 40 µm) around days 10–12. The immu-
nofluorescence analysis (Figure 3b) highlights the 
peculiar laminin localization at the cell mass 
outer perimeter, separating the spheroid from the 
surrounding extra cellular matrix. Laminin spatial 
arrangement, suggests the acquisition of a correct 
apico-basal polarization by hAEC spheroids. In 
addition, SFM was more effective in maintaining 
a stable spheroid morphology after 2 weeks of cul-
ture, while the serum-rich conditions caused the 
development of irregular and larger cell clusters 
(data not shown).
Figure 2. Stemness features and immunomodulatory properties of hAECs in SFM. (a) Immunophenotypical analysis 
of hAECs cultured in SRM and in SFM. Primary cultures of hAECs were stained with antibodies against Oct 4, SSEA-4, CD105, 
and PanCK. Representative images were chosen from five independent immune phenotyping experiments. (b) Gene expression 
levels for Ki67, NANOG, SOX2, and OCT4a. mRNAs contents of hAECs cultured in SFM (black bars) are expressed as the 
fold increase against control cells cultured in SRM (white bars). Means ± SD; n = 5. *P <0.05; **P <0.01. (c) Analysis of PBMC 
distribution in cell cycle phases after co-culture with hAECs. Co-culture of PHA-activated PBMCs with hAECs in SRM or SFM 
reduced PBMC proliferation. Data are expressed as a percentage of PBMCs for each cell cycle phase. Means ± SD; n = 6. *P <0.05; 
**P <0.01
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hAEC spheroids inhibit proliferation of mitogen-
activated PBMCs
In order to investigate if hAEC immunomodulatory 
ability was maintained even after pancreatic differ-
entiation in 3D culture system, we co-cultured 
hAEC differentiated spheroids with PHA-
stimulated PBMCs and measured BrdU incorpora-
tion levels in PBMCs (Figure 4). Non-activated 
PBMCs do not incorporate BrdU (2.8 ± 1.6%), 
while PHA-activated PBMCs regularly incorporate 
high levels of BrdU (98.6 ± 1.4%). BrdU incorpora-
tion levels significantly decreased after co-culture 
with induced (8.1 ± 5.7%) or non-induced (8.5 ± 
4.4%) hAEC spheroids (P <0.05). To conclude, no 
significant differences in inhibition activity on 
PBMC proliferation were observed between differ-
entiated and non-differentiated hAEC spheroids.
Differentiated hAEC spheroids express 
pancreatic hormones and display islet-like 
ultrastructure
To determine whether our stepwise differentiation 
protocol efficiently induced hAEC spheroids into 
hormone-producing cells, we performed immuno-
fluorescence analysis and checked for the presence 
of pancreatic hormones: glucagon and insulin 
(Figure 5a). Basal expression of glucagon was pre-
sent in undifferentiated control cells (data not 
shown), but glucagon immunoreactivity became 
more intense upon differentiation. Basal expression 
Figure 3. Development of hAEC spheroids. (a) Phase contrast micrograph of three-dimensional (3D) hAEC spheroids 
cultured on basement membrane at 7, 12, and 16 days in SFM. hAEC spheroids reached a definitive architecture after 10–12 days. 
(b) Confocal immunofluorescence analysis revealed the encircling distribution of laminin. Nuclei are counterstained with DAPI. 
Scale bars = 20 µm.
Figure 4. Immunomodulatory activity of hAEC 
spheroids. Co-culture of PHA-activated PBMCs with 
control and differentiated hAEC spheroids in SFM led to 
significant reduction in PBMC proliferation assayed by BrdU 
incorporation levels. Control and differentiated hAECs equally 
suppressed proliferation of PHA-stimulated PBMCs. Data are 
expressed as a percentage of BrdU incorporation. Means ± SD; 
n = 6. *P <0.05.
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of insulin was absent from undifferentiated hAECs. 
After 20 days of pancreatic induction in serum-free 
conditions, spheroids became insulin-positive. 
Confocal micrographs revealed the external locali-
zation of insulin-positive cells: merged images of 
immunofluorescence and phase-contrast micro-
graphs showed the membrane-related position of 
insulin, while glucagon was exclusively expressed 
in hAECs localized in the central area of the sphe-
roids. The peripheral arrangement of insulin is con-
sistent with the exocytosis mechanism for the 
release of insulin granules in response to high glu-
cose levels.
To assess the endogenous production of insulin 
and verify whether induced-hAECs formed mature 
secretory granules we used transmission electron 
microscopy (TEM) (Figure 5b). TEM ultrastruc-
tural analysis of induced hAECs (versus undiffer-
entiated control cells) revealed the high complexity 
of the cytoplasm and the presence of several vesi-
cles, consistent with intense protein synthesis. In 
particular, cells contained various secretory gran-
ules with a clear halo surrounding an electron-
dense core, which is peculiar to mature insulin- 
containing granules.
C-peptide release and expression in hAEC 
spheroids
To further confirm the endogenous nature of the 
detected insulin, C-peptide secretion assay was 
performed in differentiated and non-differentiated 
Figure 5. Pancreatic-endocrine induced hAECs express insulin. (a) Confocal immunofluorescence analysis of hormone-
expressing cells. Insulin and glucagon staining of hAEC spheroids in SFM (a–g). Insulin was localized in the peripheral areas of the 
spheroid while glucagon was located in the central mass. Phase-contrast micrograph (e) shows the structure of hAEC spheroid. 
Merge micrograph (f) highlights the strict perimembrane localization of insulin (b). The overlays (c, g) show the co-existence of 
insulin (b) and glucagon (a), expressed in different parts of the spheroid. In particular, cross-section merge micrograph (g) show 
plan x and plan y spatial organization of insulin and glucagon. Nuclei are counterstained with DAPI (d). Scale bars = 40 µm (c, f, 
g). (b) Electron micrograph of control hAECs showing normal cytoplasmatic ultrastructure (a) and pancreatic-endocrine induced 
hAEC spheroid cultured in SFM (b) showing granules with crystalline electron-dense cores, reminiscent of beta cell granules (black 
arrows). Scale bars = 1 µm.
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spheroids (control group) (Figure 6a). Basal secre-
tion of C-peptide was measured in control group at 
2 mM D-glucose and 20 mM D-glucose concentra-
tions (0.227 ± 0.027 pmol/ng DNA and 0.244 ± 
0.033 pmol/ng DNA, respectively). Pancreatic-
endocrine differentiated spheroids secreted higher 
levels (P <0.02) of C-peptide in 20 mM D-Glucose 
condition (0.697 ± 0.036 pmol/ng DNA), than dif-
ferentiated spheroids in 2 mM D-glucose condition 
(0.427 ± 0.050 pmol/ng DNA). These data further 
support the success of the differentiation protocol 
and show the acquisition of a glucose-stimulated 
insulin release mechanism from hAEC spheroids. 
Subsequently, immunofluorescence analysis per-
formed on differentiated hAEC spheroids, revealed 
a clear and widespread presence of C-peptide-
positive cells (Figure 6b).
Discussion
In this study, we propose a novel set of procedures 
to induce placental-derived hAECs into insulin-
producing cells (IPCs), combining different cell 
culture approaches in order to overcome issues 
such as the presence of animal serum in the media 
composition and cell differentiation inefficiency.
Effective and safe cell therapies require strictly 
standardized and GMP operating methodologies, 
including optimal clinically compliant culture pro-
cedures.14,15 Most of the current in vitro data 
obtained from studies on stem cells were generated 
under artificial conditions using standard culture 
media containing FBS, which may impair cell cul-
ture assay reproducibility, alter any experimental 
outcome, and delay the clinical translation.
In this regard, we first validated serum free cul-
ture condition from cell isolation to cell differentia-
tion: we concisely confirmed the outcomes from 
previous studies6,8 and extended the observations to 
our serum-free conditions. The unaltered epithelial 
morphology, the positive immunophenotype profile 
of key stemness markers (OCT4, SSEA-4), the 
growth kinetics, and the over-expression of stemness 
genes (NANOG, SOX2, OCT4a), all confirmed that 
hAEC features and stemness potential are preserved 
in serum-free conditions. In particular, we proved to 
maintain a strong proliferation rate in serum-free 
conditions without affecting the gene expression 
profile of proliferation marker Ki67.
In the second phase of our study, we focused on 
the generation of 3D spheroids from hAECs cultured 
on ECM. The vast majority of cell culture assays are 
still performed on synthetic substrates which force 
cells to adapt to a flat and rigid surface. Monolayer 
cultures compared to 3D cultures present several 
limitations concerning: viability, morphology, pro-
liferation, response to stimuli, gene and protein 
expression, and differentiation efficiency.24–26 Hence, 
Figure 6. Glucose sensing and C-peptide release/
expression in vitro. (A) C-peptide release by hAEC 
spheroids in response to hypoglycemic (2 mM D-Glucose) 
and hyperglycemic (20 mM D-Glucose) conditions. C-peptide 
levels were measured by ELISA and normalized to total DNA 
content. Non-differentiated hAEC spheroids secreted a basal 
amount of C-peptide in both conditions, while exposure to 
hyperglycemic conditions significantly increased C-peptide 
release in differentiated hAEC spheroids. Means ± SD; n = 4. 
*P <0.02. (b) Confocal immunofluorescence analysis of hAEC 
spheroids. Differentiated cells exposed to 20 mM D-Glucose 
show a widespread C-peptide (c) expression. Laminin (b) 
staining highlights its enveloping function at the spheroids 
perimeter. Merge micrograph is shown (d). Nuclei are 
counterstained with DAPI (a). Scale bar = 20 µm.
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two-dimensional (2D) culture systems scarcely 
reproduce the in vivo environment and may, thus, 
have limited predictive value for clinical applica-
tions. A more physiological context is afforded by 
3D culture methods which are more suitable for 
creating an adequate number of intercellular con-
tacts and maintaining the in vivo phenotype and 
functionality.27,28 In the last decade, several reports 
described the generation of higher-order structures 
(embryoid bodies, glandular-like acini) from stem 
cells grown in matrices or other 3D supports.16,27,29 
These studies have consistently increased our 
knowledge of several biological issues such as 
organ/tissue morphogenesis, cell growth, cancer 
development, and drug resistance.30 Therefore, 
despite the complex handling of 3D culture proce-
dures, assays performed on a 3D system hold 
higher consistency than any 2D approach.19 In the 
present study we successfully show, for the first 
time, the generation of 3D spheroids obtained from 
placenta-derived primary epithelial stem cells. 
hAEC spheroids micrographs showed the typical 
round-shaped cell aggregates. Laminin expression 
revealed the encircling distribution of the base-
ment membrane around spheroids, which suggests 
the correct acquisition of epithelial apico-basal 
polarity. The correct establishment and mainte-
nance of cell polarity are crucial for normal cell 
physiology.
At this stage, we tested whether in vitro 3D cul-
ture was a valid approach to expand and efficiently 
differentiate hAECs into IPCs. Stepwise differen-
tiation protocols applied to monolayer culture sys-
tems still remain the most adopted solutions to 
obtain IPCs from hESCs, iPS cells3,31,32 and mes-
enchymal stem cells (MSCs).33 Recently, Takeuchi 
et al.,21 showed that pancreatic-endocrine differ-
entiation of hESCs cells cultured in monolayer, 
produced insulin-positive cells unable to secrete 
insulin in response to glucose stimulation, while 
3D culture cell aggregates became functional 
IPCs. Although previous studies reported consid-
erable evidence about successful insulin produc-
tion from different stem cells,34 setting up an in 
vitro procedure to differentiate hAECs into IPCs 
has been a substantial task. We initially had per-
formed direct differentiation with Nicotinamide as 
others reported,6,35 which only led to sporadic 
expression of insulin (data not shown) and no 
insulin secretion in response to glucose. Therefore, 
to emulate the in vivo pancreatic development 
pathway, we adapted, for our study on hAECs, the 
stepwise differentiation protocols from previous 
reports.11,31,32 SFM was used throughout the entire 
differentiation process and only three induction 
molecules were employed: Activin A, in the pre-
induction phase, to drive the endoderm forma-
tion;36 Nicotinamide (NAM), with Activin A in the 
second stage, to induce pancreatic-endocrine dif-
ferentiation;37 and finally RA with NAM to pro-
mote IPC formation.38 Differentiated hAEC 
spheroids displayed insulin in the outer part of the 
spheroid and no consistent trace in the central 
core, where cells displayed an alpha cell pheno-
type (glucagon expression). Confocal micrographs 
revealed a defined cell membrane-associated 
localization of insulin. Here, as shown by TEM 
analysis, mature insulin-containing granules are 
gathered and eventually release their hormone 
content. C-peptide analysis undoubtedly con-
firmed the synthesis of insulin and revealed the 
glucose-dependent insulin secretion. The data 
showed the presence and production of insulin 
from a relatively limited number of hAECs (60,000 
cells plated for each condition) and the fold 
increase of hormone produced by differentiated 
hAEC spheroids is comparable to analogous in 
vitro studies performed with adult stem cells.39
One of the most important characteristics 
required from candidate stem cells for regenerative 
medicine, is the ability to not elicit any immune 
response when transplanted. Culture procedures 
(passages, differentiation, 3D cultures) might com-
promise the immunomodulatory activity of cells 
that become no longer suitable for cell therapy 
approaches. Thus, besides the evaluations that led 
us to the derivation of insulin-producing cells, we 
simultaneously tested hAECs for their immu-
nomodulatory properties in vitro. During serum-
free validation we showed that FBS deprivation 
does not alter hAEC ability to inhibit PHA-activated 
PBMC proliferation in monolayer co-cultures. The 
same scenario was detected in hAEC spheroids: 
comparison between non-differentiated hAEC 
spheroids and differentiated hAEC spheroids 
(Figure 4) showed the same robust immunomodu-
lation. Hence, hAEC spheroids maintained the 
immunomodulatory properties observed in mon-
olayer cultures. Collectively, our results suggested 
that neither the cell transcriptome variations from 
2D to 3D culture, nor the secretome modifications40 
upon differentiation altered the immunogenicity of 
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hAECs, which might, therefore, be suitable for 
transplantation.
In sum, our findings show the first attempt of 
hAEC pancreatic-endocrine differentiation, per-
formed with the combination of serum-free culture 
condition, 3D multicellular spheroids creation, and 
stepwise differentiation protocol. The encouraging 
outcomes presented here usefully contribute to the 
implementation of similar procedures for in-depth 
in vitro and in vivo experiments, and highlight the 
role of hAECs as a possible cell therapy source for 
incurable diseases like diabetes.
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